(19)
(11) EP 3 536 367 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.09.2021 Bulletin 2021/37

(45) Mention of the grant of the patent:
11.08.2021 Bulletin 2021/32

(21) Application number: 18160818.3

(22) Date of filing: 08.03.2018
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 15/0086; A61M 2205/3306; A61M 2205/502; A61M 2205/581; A61M 2205/583; A61M 2205/584; A61M 2205/59; A61M 2205/6063; A61M 15/0016

(54)

MEDICATION INHALER FOR AEROSOL PULMONARY DELIVERY WITH SPECIFIC PATTERN RECOGNIZABLE BY AN ELECTRONIC DEVICE

ARZNEIMITTELINHALATOR ZUR AEROSOL-LUNGENVERABREICHUNG MIT SPEZIFISCHEM, DURCH EINE ELEKTRONISCHE VORRICHTUNG ERKENNBAREM MUSTER

INHALATEUR DE MÉDICAMENT POUR ADMINISTRATION PULMONAIRE D'AÉROSOL AVEC MOTIF SPÉCIFIQUE RECONNAISSABLE PAR UN DISPOSITIF ÉLECTRONIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
11.09.2019 Bulletin 2019/37

(73) Proprietor: Air Liquide Medical Systems S.r.l.
20158 Milano (IT)

(72) Inventors:
  • POLLINI, Marco
    25073 Bovezzo (IT)
  • RUOCCO, Alessandra
    25030 Orzivecchi (IT)
  • ALBERICI, Luca
    25030 RONCADELLE (IT)

(74) Representative: Air Liquide 
L'Air Liquide S.A. Direction de la Propriété Intellectuelle 75, Quai d'Orsay
75321 Paris Cedex 07
75321 Paris Cedex 07 (FR)


(56) References cited: : 
WO-A1-2012/038861
US-A- 6 039 042
US-A1- 2013 063 579
 FR-A1- 3 021 544
US-A1- 2012 318 261
US-A1- 2015 339 953
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).